Pharmaceutical-related exchange-traded funds were among few winners of Tuesday's session, thanks to a gain of more than 5% in
A judge ruled in favor of Bristol-Myers and blocked a generic version of the Plavix blood-thinning drug. Bristol-Myers, which sells the drug in the U.S, was recently up $1.42, or 4.7%, to $31.73. France-based
, which holds the patent to the Plavix drug, was also higher.
was recently up 41 cents, or 0.5%, to $83.27. The
iShares Dow Jones U.S. Pharmaceuticals
ETF was adding 3 cents, or 0.1%, to $57.47.
On the losing side, bundled securities tracking semiconductors were among the worst performers. Among individual names,
Advanced Micro Devices
were lower by 1% or more.
Ultra Semiconductor ProShares
ETF was losing $1.32, or 1.5%, to $84.54. The
PowerShares Dynamic Semiconductors
ETF fell 17 cents, or 0.9%, to $19.49. The
iShares Goldman Sachs Semiconductor
ETF was easing by 58 cents, or 0.9%, to $65.97. The
ETF was 21 cents, or 0.5%, lower at $38.04.
Housing-related ETFs were among losers. Earlier, a government report said U.S. housing starts fell a greater-than-expected 2.1% in May to 1.47 million annualized units. On average, economists were looking for new construction to total 1.48 million units.
ETF was down 21 cents, or 0.5%, to $32.61. The
iShares Dow Jones U.S. Home Construction
ETF was recently falling by 4 cents, or 0.2%, at $33.86.
Energy-related ETFs were also lower, as crude oil pulled back from a near 10-month high. The front-month crude contract was down 41 cents to $68.68 a barrel, and gasoline was losing 3 cents at $2.22 a gallon.
SPDR S&P Oil & Gas Exploration & Production
ETF was off 29 cents, or 0.6%, to $48.82. The
PowerShares DB Oil
was down 22 cents, or 0.8%, to $27.19. The
iShares Dow Jones U.S. Oil & Gas Exploration Index
was lower by 33 cents, or 0.5%, to $61.92. The
PowerShares Dynamic Energy Exploration
fell 10 cents, or 0.4%, to $24.01.